LiftmyCVLiftmyCV
C(

Therapeutic Area Biomarker Director - Cardiovascular and Metabolism

C028 (FCRS = CH028) Novartis Pharma AGHybridCambridge, US$142,100–$263,900 per year
AI job summary

As the Therapeutic Area Biomarker Director for Cardiovascular and Metabolism at Novartis, you will lead the development of fit-for-purpose biomarker strategies in a hybrid work setting. Your responsibilities include guiding clinical project teams, integrating data science to drive precision medicine initiatives, and collaborating with a dedicated matrix team. You will represent biomarker development on decision boards and lead efforts to analyze large-scale patient data to identify new indications. A strong clinical background in cardiovascular diseases is preferred, along with leadership experience in both academic and commercial settings.

Job description

Job Description Summary

As a Cardiovascular and Metabolism (CVM) Therapeutic Area Biomarker Lead (TABL) (Director) you will lead the CVM disease area biomarker matrix team and be responsible for the development and implementation of “fit for purpose” biomarker strategies and providing an effective interface for transitioning projects from early to later stage clinical development. You will be a core member of CVM clinical project teams, engaged in Translational Data Science teams, and provide therapeutic area line function review for clinical protocols. As a TABL you will lead efforts to identify, develop, and drive disease, mechanistic and compound biology that serves the clinical and precision medicine approaches for the multi-indication CVM portfolio that focuses on heart failure, atherosclerosis, obesity and atrial fibrillation indications.

Key Responsibilities:

  • Delivering clinical project and disease biomarker strategies and plans across the early through late phase within the Cardiovascular and Metabolism portfolio and support relevant mature assets in the late phase portfolio
  • Leading a dedicated matrixed group of Subject Matter Experts and project team representatives as well as key program stakeholders, to together develop biomarkers strategies for disease and/or assets across the Research-Development-Commercial continuum
  • Representing Biomarker Development on Cardiovascular and Metabolism early and late Disease Area Decision Boards to identify, develop, and drive cardiovascular and metabolic disease and compound mechanistic biology, and precision medicine approaches for the portfolio
  • Leading strategic translational data working groups centered on integrating and analyzing large-scale patient multi-modal data sets (omics, imaging, digital, etc.) to identify new indications, endpoints, and responsive patient subpopulations
  • Representing BMD line functions in Therapeutic Area Line Function committees for clinical protocol development and operational milestone reviews
  • Leading biomarker strategies and drive plans at the clinical team level as a Biomarker Strategy Lead
  • Lead and/or contribute to BMD/TM/BR wide initiatives e.g. genetics, inflammation, imaging depending on background and expertise
  • Stay up to date on clinical, disease, biology and scientific literature and competitor data for their respective disease areas
  • Implementing strategies in close collaboration with the BMD global organization which includes over 150 associates with expertise in all aspects of biomarker science i.e. genetics, genomics, molecular and cellular, digital devices, imaging and data sciences
  • Design and present the RDC biomarker strategy for transitioning and mature assets for late phase within their key pillar and ensuring study level alignment across the portfolio segment of focus

Essential Requirements:

  • MD, MD/PhD, or PhD degree required, plus additional PhD/postdoc or equivalent level research
  • Deep understanding of cardiovascular and metabolic disease epidemiology with particular emphasis on Atherosclerotic Cardiovascular Disease (ASCVD) that can be applied to questions of diagnosis, biomarker development and treatment monitoring strongly preferred
  • Scientific excellence supported by recognized high quality publications; clinical and/or biological expertise in cardiovascular and metabolic diseases (Board certified or similar level preferred) with impact in ASCVD literature
  • 5 plus years of independent leadership experience and external leadership/partnership in consortia and/or health authority initiatives
  • Proven success in leading and partnering in multidisciplinary matrix teams across Pharma/biotech (clinical research thru healthcare applications), academic institutions, or commercial business functions including a mature biomarker strategy to support registration and/or launch
  • Demonstrated ability to own an entire section of the portfolio as well as the phase package; Well-developed interpersonal skills with good presence and ability to influence and negotiate with senior leadership; experienced presenter and communicator
  • Significant relevant experience after your MD/PhD/postdoc including quantitative expertise in biostatistics, bioinformatics, computer biology, statistical genetics, clinical imaging, machine learning, or data science; interpreting and publishing studies consisting of “omics” data e.g. genetics, genomics, proteomics; closely partnering with/leading data scientists
  • Fluent in oral and written English; other languages e.g. German, French, Italian useful but not required

Benefits & Rewards

At Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen.

Expected Annual Base Salary Range for role:

142,100.00 - 203,000.00 - 263,900.00 CHF Annual The base salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically. In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters. The rewards of being part of our team go far beyond base pay and incentives. We also offer a variety of competitive benefits in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs. In addition, we provide flexible and hybrid working options, where possible, and minimum 14 weeks paid parental leave. Pay equity is a fundamental principle of our employment policy and reflects our commitment to create a diverse, equitable and inclusive environment that treats all employees with dignity and respect, as outlined in our Code of Ethics.

Skills Desired

  • Accountability
  • Chemical Biology
  • Clinical Research
  • Clinical Trials
  • Collaboration
  • Decision Making
  • Drug Development
  • Immunology
  • Influencing Skills
  • Leadership
  • Medical Research
  • Mentorship
  • Molecular Biology
  • Stakeholder Engagement
  • Stakeholder Management
  • Strategic Thinking
  • Team Management

Job details

Published
August 31, 2026
Job source
myworkdayjobs
Workplace
Hybrid · Cambridge, US
First seen
August 31, 2026
AI match explained

See how well you match this job

Log in or sign up and Eva will compare your profile with this role, explain your strengths and show what to improve.

Sign up to see your matchAlready have an account? Log in

More at C028 (FCRS = CH028) Novartis Pharma AG

Similar jobs from this company

None listed.

Across the market

Similar jobs from other companies

Third-party content disclaimer

Full job descriptions are sourced directly from third-party applicant tracking systems (ATS), job boards, recruitment platforms, and employer career pages.

LiftmyCV does not claim ownership of this content or guarantee its accuracy or current availability. All original content is the intellectual property of the respective employers or other rights holders.

LiftmyCV hiring intelligence, availability checks, and related-job recommendations are generated from LiftmyCV data and public sources.

If you prefer, you may apply directly via the original listing for transparency.